EGA PRESIDENT NICK HAGGAR WANTS PARTNERSHIP WITH ITALIAN GOVERNMENT FOR SUSTAINABILITY OF HEALTHCARE
Rome, 9 April 2014 - EGA President Nick Haggar attended the “Stati Generali della Salute” Conference in Rome on the 8th and 9th of April at the invitation of Italian Minister of Health, Beatrice Lorenzin. The conference was attended by European and Italian policy makers and stakeholders discussing the main challenges affecting the health sector in Italy.
THE EUROPEAN HEALTHCARE COMMUNITY IS PARTNERING TO ADDRESS UNIVERSAL ACCESS TO HEALTH AS A PRIORITY FOR THE FORTHCOMING EUROPEAN PARLIAMENT
Brussels, 8 April 2014 - Today, Adrian van den Hoven, EGA Director General, calls for strong partnership between EU politicians, national governments and the healthcare community to promote universal and equitable access for patients to quality healthcare.
THE EUROPEAN BIOSIMILARS GROUP CALLS UPON NATIONAL AUTHORITIES AND MEDICAL SOCIETIES TO ACTIVELY ENGAGE IN REDUCING THE KNOWLEDGE GAP ABOUT BIOSIMILAR MEDICINES
London, 3 April 2014 - Around 250 delegates from 34 countries, including 63 authorities and academics, have joined the 12th EGA International Biosimilar Medicines Conference, organised by the European Biosimilars Group (EBG), EGA Sector Group, to discuss the challenges and the opportunities that biosimilar medicines provide for patients and society at large.
The EGA welcomes the publication of the Guiding Principles Promoting Good Governance in the Pharmaceutical Sector
25 - 27 June 2014
21 January 2015
22 - 23 January 2015
23 - 24 April 2015
More details available in November 2014
KPMG Report - Advice on the implementation of EU-Directive 2011/62/EU
Advice on the implementation of EU-Directive 2011/62/EU
KPMG Report Download PDF
EGA Biosimilars Handbook
EGA Biosimilars Handbook EGA_BIOSIMILARS_handbook_en.pdf
EGA Biosimilars Handbook Italian version EGA_BIOSIMILARS_IT.pdf
EGA Q&A on the revised EMA Bioequivalence Guideline
EGA Q&A on the revised EMA Bioequivalence Guideline, the EGA Contribution to the Promotion of Harmonised EU interpretation of the revised Bioequivalence Requirement dowload PDF
EGA Vision 2015, the Way forward for more Efficient Regulatory Environment for Generic and Biosimilar Medicines